| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 259,6 k € | -6.5% | 277,6 k € | +18.9% | 233,4 k € | +486.6% | 39,8 k € | -71.8% | 141,1 k € | +148.6% | 56,8 k € | +38.5% | 41,0 k € | -43.1% | 72,0 k € | +102.8% | 35,5 k € | -38.7% | 57,9 k € | +53.1% | 37,8 k € | -61.3% | 97,6 k € | +9.3% | 89,3 k € | -8.4% | 97,5 k € | +9.9% | 88,7 k € | +11.2% | 79,8 k € | -22.9% | 103,5 k € | +49.0% | 69,5 k € | -23.5% | 90,8 k € | -3.3% | 93,9 k € | |
| EBITDA | 257,1 k € | -6.5% | 274,9 k € | +18.9% | 231,3 k € | +524.5% | 37,0 k € | -73.2% | 138,0 k € | +152.4% | 54,7 k € | +38.8% | 39,4 k € | -43.8% | 70,1 k € | +114.0% | 32,8 k € | -41.6% | 56,2 k € | +58.3% | 35,5 k € | -63.2% | 96,5 k € | +11.0% | 86,9 k € | -9.2% | 95,7 k € | +10.2% | 86,9 k € | +11.7% | 77,8 k € | -23.9% | 102,3 k € | +51.3% | 67,6 k € | -24.1% | 89,1 k € | -4.1% | 92,9 k € | |
| Operating profit | 249,2 k € | -3.9% | 259,5 k € | +19.0% | 218,0 k € | +870.3% | 22,5 k € | -81.2% | 119,8 k € | +206.0% | 39,1 k € | +115.7% | 18,1 k € | -58.0% | 43,2 k € | +222.8% | 13,4 k € | -58.8% | 32,5 k € | +127.4% | 14,3 k € | -79.9% | 71,0 k € | +9.5% | 64,8 k € | +9.5% | 59,2 k € | +39.1% | 42,5 k € | +33.2% | 31,9 k € | -42.4% | 55,5 k € | +136.1% | 23,5 k € | -48.2% | 45,3 k € | -9.4% | 50,0 k € | |
| Profit/loss | 184,1 k € | -0.5% | 185,1 k € | +12.3% | 164,9 k € | +2211.0% | -7,8 k € | -109.9% | 79,1 k € | +176.4% | 28,6 k € | +77.8% | 16,1 k € | -16.3% | 19,2 k € | +32.9% | 14,5 k € | -17.0% | 17,5 k € | +743.1% | 2,1 k € | -95.5% | 46,1 k € | -6.8% | 49,5 k € | +11.4% | 44,4 k € | +47.7% | 30,1 k € | +38.0% | 21,8 k € | -48.0% | 41,9 k € | +168.7% | 15,6 k € | -47.0% | 29,4 k € | -8.7% | 32,2 k € | |
| Equity | 887,5 k € | +26.2% | 703,3 k € | +35.7% | 518,2 k € | +46.6% | 353,4 k € | -2.2% | 361,2 k € | +28.1% | 282,1 k € | +11.3% | 253,4 k € | +6.8% | 237,3 k € | -41.0% | 402,2 k € | +3.7% | 387,7 k € | +4.7% | 370,2 k € | +0.6% | 368,2 k € | +14.3% | 322,1 k € | +9.9% | 293,0 k € | +17.9% | 248,6 k € | +13.8% | 218,5 k € | +11.1% | 196,7 k € | +27.1% | 154,8 k € | +11.2% | 139,2 k € | +26.8% | 109,8 k € | |
| Total assets | 977,5 k € | +19.4% | 818,8 k € | +34.8% | 607,4 k € | +35.8% | 447,4 k € | +4.4% | 428,7 k € | +29.6% | 330,7 k € | +14.1% | 289,7 k € | -6.2% | 309,0 k € | -30.1% | 441,9 k € | +7.9% | 409,7 k € | +2.9% | 398,1 k € | -0.6% | 400,5 k € | +12.0% | 357,5 k € | +10.9% | 322,4 k € | +10.1% | 293,0 k € | -0.2% | 293,5 k € | +3.1% | 284,6 k € | +30.1% | 218,8 k € | -1.6% | 222,3 k € | -6.5% | 237,6 k € | |
| Cash | 112,0 k € | -50.6% | 226,7 k € | +342.3% | 51,2 k € | +45.4% | 35,2 k € | -37.1% | 56,0 k € | -1.1% | 56,6 k € | +11.0% | 51,0 k € | -21.5% | 64,9 k € | -31.9% | 95,3 k € | +16.4% | 81,9 k € | +40.7% | 58,2 k € | -47.7% | 111,3 k € | +81.6% | 61,3 k € | -26.5% | 83,4 k € | +21.2% | 68,8 k € | +16.8% | 58,9 k € | +159.5% | 22,7 k € | -32.6% | 33,7 k € | -35.8% | 52,4 k € | +38.3% | 37,9 k € | |
| Debts | 90,1 k € | -22.0% | 115,4 k € | +29.5% | 89,1 k € | -5.2% | 94,0 k € | +39.3% | 67,5 k € | +38.9% | 48,6 k € | +34.0% | 36,3 k € | -49.4% | 71,7 k € | +80.3% | 39,7 k € | +80.6% | 22,0 k € | -21.1% | 27,9 k € | -13.9% | 32,4 k € | -6.7% | 34,7 k € | +21.4% | 28,6 k € | -34.3% | 43,5 k € | -41.3% | 74,1 k € | -14.8% | 86,9 k € | +38.0% | 63,0 k € | -23.3% | 82,1 k € | -35.3% | 126,8 k € | |
Private limited company · Beauraing · incorporated on 09/04/2003
Private limited company profitable and well capitalised. Cash position declining (-50.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
BEAURAING MEDICAL is a Private limited company incorporated in 2003. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Beauraing.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette